Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hogy Medical CoHGYMF 57 EBITDA Margin % is 21.66% as of Dec. 2025, which is 27% below its 10-year median of 29.74. GuruFocus rates HGYMF with a GF Score™ of 57/100 and a GF Value™ of $23.24. The stock has 10 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Hogy Medical Co ranks better than 70.83% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hogy Medical Co's EBITDA for the
three
months ended in Dec. 2025 was $13.7 Mil. Hogy Medical Co's Revenue for the
three
months ended in Dec. 2025 was $63.3 Mil. Therefore, Hogy Medical Co's EBITDA margin for the quarter that ended in Dec. 2025 was 21.66%.
Hogy Medical Co (OTCPK:HGYMF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Hogy Medical Co EBITDA Margin % Related Terms
Hogy Medical Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Hogy Medical Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HGYMF vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Hogy Medical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hogy Medical Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hogy Medical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Hogy Medical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hogy Medical Co (HGYMF) has a EBITDA Margin % of 21.66% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hogy Medical Co and its competitors. This is 27% below median its historical median of 29.74. Over the past decade, Hogy Medical Co's EBITDA Margin % has ranged from 17.52 to 34.94. According to the industry distribution chart, Hogy Medical Co ranks #238 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 29.2%.
Is Hogy Medical Co's EBITDA Margin % too high?
Hogy Medical Co's current EBITDA Margin % of 21.66% is 27% below median its 10-year median of 29.74. Over the past 10 years, this metric has ranged from a low of 17.52 to a high of 34.94. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Hogy Medical Co's value of 21.66% is 189.8% above this industry median. Based on the distribution chart, Hogy Medical Co ranks #238 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hogy Medical Co has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hogy Medical Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Hogy Medical Co ranks #238 out of 816 companies for EBITDA Margin %. This puts Hogy Medical Co in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Hogy Medical Co's value of 21.66% is 189.8% above this benchmark. Historically, Hogy Medical Co's own EBITDA Margin % has ranged from 17.52 to 34.94 over the past decade. While the company's 10-year median is 29.74 vs. the industry median of 7.48, Hogy Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hogy Medical Co's current EBITDA Margin % of 21.66% is 189.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hogy Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hogy Medical Co's current EBITDA Margin % is 21.66%, which is 27% below median its own 10-year median of 29.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hogy Medical Co stock overvalued right now?
Hogy Medical Co (HGYMF) has a current EBITDA Margin % of 21.66%. The stock's GF Value™ is $23.24, compared to a current price of $34.99 — trading 50.6% above its estimated fair value. The current EBITDA Margin % is 21.66%, which is 27% below median its 10-year median of 29.74 and 189.8% above the Medical Devices & Instruments industry median of 7.48. Hogy Medical Co's overall GF Score™ is 57/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hogy Medical Co (HGYMF), the current EBITDA Margin % is 21.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hogy Medical Co (HGYMF) Overvalued in 2026?
Based on GuruFocus' analysis, Hogy Medical Co stock appears to be overvalued.
The current stock price of $34.99 is trading 50.6% above its estimated GF Value™ of $23.24.
Key valuation signals for HGYMF:
EBITDA Margin %: 21.66% (27% below median its 10-year median of 29.74)
GF Value™: $23.24 vs. price of $34.99 (50.6% above fair value)
Industry Position: 189.8% above the Medical Devices & Instruments median (#238 of 816)
No single metric tells the full story. See the HGYMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hogy Medical Co Ltd develops and sells products that can be used to streamline operations and improve safety at healthcare facilities. Its products are used in hospitals' operating rooms, wards, material rooms, and administrative settings. Hogy Medical receives the majority of its revenue from sales of surgical-use products. Its key products include kit products, nonwoven products, and sterilization products. The kit products contain sterilized surgical supplies for use in a specific operation. The nonwoven products include gowns, caps, equipment covers, and other accessories. Hogy's primary sterilization product is the Mekkin bag, a sterilization pouch. The vast majority of Hogy's revenue is generated in Japan.
57GF Score
Get the complete analysis for HGYMF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HGYMF has been successfully added to your 
